genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2019
Dermatitis
Drug Discovery
Aslan Acquires Full Rights to CSL Atopic Dermatitis Candidate for $780M+
Featured
Dietary Salt Mediates Allergic Diseases
News
Bee Venom Takes the Sting Out of Eczema
Drug Discovery
Novartis Licenses MorphoSys/Galapagos Atopic Dermatitis Candidate MOR106 for $1.1B+
Drug Discovery
Menlo Therapeutics Files for Up-to-$97.75M IPO
Drug Discovery
U.K. Okays Early Access to Sanofi, Regeneron Atopic Dermatitis Drug Dupilumab
Industry News
DS Biopharma Spins Out Afimmune
Industry News
Bavarian Nordic Wins $100M Bulk Supply Order from BARDA for Imvamune
Drug Discovery
Regeneron Joins Human Vaccines Project
Drug Discovery
GSK Ends Effort to Commercialize Basilea’s Eczema Drug in U.S.
1
2
3
4
...
6
Page 3 of 6
Scroll Up
Scroll Up
